Literature DB >> 3161887

Effect of ATP on phosphofructokinase-2 from Escherichia coli. A mutant enzyme altered in the allosteric site for MgATP.

V Guixé, J Babul.   

Abstract

The activity of Escherichia coli phosphofructokinase-2 (Pfk-2) and of the mutant enzyme Pfk-2* was measured over a wide range of Mg2+ and ATP concentrations. MgATP2- inhibited only the Pfk-2 enzyme, with a degree of cooperativity of 1.5. This inhibition was relieved upon increasing the fructose-6-P concentration or by lowering the pH of the reaction mixture. Other nucleotides used as phosphate donors instead of ATP did not inhibit. MgATP2- was the true substrate for both enzymes and their Km values for this compound were not affected by an increase of the free Mg2+ concentration. However, free Mg2+ partially relieved the MgATP2- inhibition of Pfk-2 under conditions where the ATP4- concentration was negligible, without changes in the degree of cooperativity. ATP4- acted as a strong competitive inhibitor of both Pfk-2 and Pfk-2* with respect to MgATP2- with Ki values of 10 and 8 microM, respectively. ADP, AMP, and cAMP did not prevent the MgATP2- inhibition of Pfk-2. These results suggest the presence of an allosteric site for MgATP2- in Pfk-2 responsible for the MgATP2- inhibition, which is altered in Pfk-2* as a consequence of the structural mutation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3161887

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Crystallization and preliminary crystallographic analysis of the tetrameric form of phosphofructokinase-2 from Escherichia coli, a member of the ribokinase family.

Authors:  Ricardo Cabrera; Andrés Caniuguir; Andre L B Ambrosio; Victoria Guixé; Richard C Garratt; Jorge Babul
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-08-26

2.  A mutant phosphofructokinase produces a futile cycle during gluconeogenesis in Escherichia coli.

Authors:  J C Torres; V Guixé; J Babul
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

3.  Flexible Metabolism and Suppression of Latent Enzymes Are Important for Escherichia coli Adaptation to Diverse Environments within the Host.

Authors:  Christopher J Alteri; Stephanie D Himpsl; Allyson E Shea; Harry L T Mobley
Journal:  J Bacteriol       Date:  2019-07-24       Impact factor: 3.490

4.  A ribokinase family conserved monovalent cation binding site enhances the MgATP-induced inhibition in E. coli phosphofructokinase-2.

Authors:  Mauricio Baez; Ricardo Cabrera; Humberto M Pereira; Alejandro Blanco; Pablo Villalobos; César A Ramírez-Sarmiento; Andrés Caniuguir; Victoria Guixé; Richard C Garratt; Jorge Babul
Journal:  Biophys J       Date:  2013-07-02       Impact factor: 4.033

5.  The crystal complex of phosphofructokinase-2 of Escherichia coli with fructose-6-phosphate: kinetic and structural analysis of the allosteric ATP inhibition.

Authors:  Ricardo Cabrera; Mauricio Baez; Humberto M Pereira; Andrés Caniuguir; Richard C Garratt; Jorge Babul
Journal:  J Biol Chem       Date:  2010-12-08       Impact factor: 5.157

6.  Structural and functional roles of Cys-238 and Cys-295 in Escherichia coli phosphofructokinase-2.

Authors:  Mauricio Baez; Patricio H Rodríguez; Jorge Babul; Victoria Guixé
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

7.  Expression of phosphofructokinase in Neisseria meningitidis.

Authors:  Gino J E Baart; Marc Langenhof; Bas van de Waterbeemd; Hendrik-Jan Hamstra; Bert Zomer; Leo A van der Pol; E C Beuvery; Johannes Tramper; Dirk E Martens
Journal:  Microbiology (Reading)       Date:  2009-10-01       Impact factor: 2.777

8.  Molecular Basis of Sulfosugar Selectivity in Sulfoglycolysis.

Authors:  Mahima Sharma; Palika Abayakoon; Ruwan Epa; Yi Jin; James P Lingford; Tomohiro Shimada; Masahiro Nakano; Janice W-Y Mui; Akira Ishihama; Ethan D Goddard-Borger; Gideon J Davies; Spencer J Williams
Journal:  ACS Cent Sci       Date:  2021-02-23       Impact factor: 14.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.